Japan Tobacco Inc. announced resolutions from the Board of Directors concerning the Company's new executive appointment. Newly appointed Executive Officer (Effective from July 1, 2024): Takayuki Yamaguchi as Senior Vice President, President, Pharmaceutical Business. Resigning Executive Officer (As of June 30, 2024): Muneaki Fujimoto as Senior Vice President, President, Pharmaceutical Business.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,451 JPY | +0.91% | +1.74% | +22.11% |
14/05 | Jefferies Adjusts Japan Tobacco’s Price Target to 3,741 Yen From 3,353 Yen, Keeps at Hold | MT |
10/05 | Japan Tobacco's Attributable Profit Up 9% in Q1 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.11% | 50.38B | |
+14.23% | 79.15B | |
-5.51% | 65.44B | |
+2.76% | 7.44B | |
-11.73% | 5.76B | |
+2.00% | 2.59B | |
-4.80% | 2.33B | |
-34.18% | 1.57B | |
-14.24% | 1.21B | |
-14.08% | 1.16B |
- Stock Market
- Equities
- 2914 Stock
- News Japan Tobacco, Inc.
- Japan Tobacco Inc. Announces Executive Changes